Protalix BioTherapeutics, Inc. (NYSEMKT:PLX)

CAPS Rating: 3 out of 5

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Results 1 - 20 of 30 : 1 2 Next »

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 PLX Score: -79.65

IHS pattern

Recs

1
Member Avatar TMFBiologyFool (96.78) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 PLX Score: +121.27

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Recs

0
Member Avatar YORGILL (< 20) Submitted: 3/11/2011 2:05:26 PM : Outperform Start Price: $6.25 PLX Score: -129.28

Great innovative platform with big potential for biosimilars

Recs

0
Member Avatar reachmygoals1 (< 20) Submitted: 1/29/2011 4:23:49 PM : Outperform Start Price: $9.28 PLX Score: -139.84

$20 after fda approval...over $30 if they get a buyout after fda approval

Recs

0
Member Avatar eitanbilu (< 20) Submitted: 12/8/2010 11:22:53 AM : Outperform Start Price: $8.68 PLX Score: -145.39

no doubts !

Recs

0
Member Avatar Biotech2010 (55.76) Submitted: 1/26/2010 8:50:26 PM : Outperform Start Price: $7.25 PLX Score: -162.37

@7.02

Recs

0
Member Avatar luebypopoff (28.74) Submitted: 12/30/2009 7:37:33 PM : Outperform Start Price: $6.70 PLX Score: -154.89

Shorts are driving stock down, but has deal with Pfizer, a new drug about to be released, and others in the pipeline.

Recs

0
Member Avatar movadoman51 (< 20) Submitted: 11/4/2009 12:37:36 AM : Outperform Start Price: $10.93 PLX Score: -175.48

New technology!!! will bit all pharma co.

Recs

0
Member Avatar Displacement (< 20) Submitted: 9/28/2009 4:24:48 PM : Outperform Start Price: $8.27 PLX Score: -169.41

Surprising performance for my contrarians' box

Recs

0
Member Avatar Thelmal (30.41) Submitted: 9/25/2009 8:07:36 AM : Outperform Start Price: $7.60 PLX Score: -170.94

Forward thinking Biotech Company

Recs

0
Member Avatar hrefael77 (22.25) Submitted: 9/2/2009 1:19:08 PM : Outperform Start Price: $7.10 PLX Score: -179.12

SUCCESEE IN THE iii PHASE

Recs

0
Member Avatar yshoshany (< 20) Submitted: 7/24/2009 9:25:07 AM : Outperform Start Price: $6.20 PLX Score: -182.38

great technology

Recs

0
Member Avatar LandWayland (< 20) Submitted: 7/17/2009 8:15:38 PM : Outperform Start Price: $5.48 PLX Score: -184.86

This company has developed a radical new technology for cheaply generating biological components for making complex drugs. Their first drug has successfully completed FDA Phase III trials and will soon be on the market with a potential annual sales in excess of $1 billion.

Recs

0
Member Avatar floyd28 (< 20) Submitted: 7/16/2009 11:11:08 PM : Outperform Start Price: $5.56 PLX Score: -186.58

Protalix is re inventing the wheel and that means it will be probably bought by a bigger company in a high price which will make the holders happy.
If it wont be bought (or wont be sold) then I personally believe it will be a major player and the stock's price right now will sound like a joke in a few years from now.

A risk, yes! but today most investments have risks within them at least here we know that the reward can be worthwhile.

That is my personal opinion only - not a recommendation!

Recs

0
Member Avatar esqdrew (< 20) Submitted: 6/27/2009 8:20:16 PM : Outperform Start Price: $4.90 PLX Score: -187.54

Because Philip Frost is involved and because PLX is in Phase III of its testing of prGCD and if the results turn out well this stock will explode.

Recs

0
Member Avatar crapsshooter (85.05) Submitted: 2/13/2009 12:21:14 PM : Outperform Start Price: $2.64 PLX Score: -188.03

There have been no Serious Adverse Events reported in connection with the phase III clinical trial. I bought in at 1.38 and this has been going up so therefore i am going very long

Recs

3
Member Avatar yellowear (56.87) Submitted: 12/20/2008 12:32:36 PM : Outperform Start Price: $1.62 PLX Score: -136.14

Based on the news on the street and the performance of the stock at these levels, this company has the potential of reaching 2000% in the next 4 years. This stock has found a bottom like AKS did several years ago which reached a high of 70+ before it cratered. This is a 'Just about Perfect' time to start to buy this stock!

Recs

0
Member Avatar acodalbu (81.09) Submitted: 12/5/2008 4:26:33 PM : Outperform Start Price: $1.62 PLX Score: -136.14

cheap, dynamic enzyme replacement therapy. How has genentech or Genzyme not bought this out yes, i have no idea

Recs

0
Member Avatar joshperi (< 20) Submitted: 5/30/2008 3:22:59 PM : Outperform Start Price: $3.15 PLX Score: -100.81

advanced biotechnology

Recs

0
Member Avatar rockhound69 (< 20) Submitted: 5/25/2008 10:42:25 PM : Outperform Start Price: $3.10 PLX Score: -102.84

curve ball

Results 1 - 20 of 30 : 1 2 Next »

Featured Broker Partners


Advertisement